» Articles » PMID: 26742953

A TOMM40 Poly-T Variant Modulates Gene Expression and is Associated with Vocabulary Ability and Decline in Nonpathologic Aging

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 2016 Jan 9
PMID 26742953
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The Translocase of Outer Mitochondrial Membrane 40 Homolog and Apolipoprotein E (TOMM40-APOE) locus has been associated with a number of age-related phenotypes in humans including nonpathologic cognitive aging, late-onset Alzheimer's disease, and longevity. Here, we investigate the influence of the TOMM40 intron 6 poly-T variant (rs10524523) on TOMM40 gene expression and cognitive abilities and decline in a cohort of 1613 community-dwelling elderly volunteers who had been followed for changes in cognitive functioning over a period of 14 years (range = 12-18 years). We showed that the shorter length poly-T variants were found to act as a repressor of luciferase gene expression in reporter gene constructs. Expression was reduced to approximately half of that observed for the very long variant. We further observed that the shorter poly-T variant was significantly associated with reduced vocabulary ability and a slower rate of vocabulary decline with age compared to the very long poly-T variants. No significant associations were observed for memory, fluid intelligence or processing speed, although the direction of effect, where the short variant was correlated with reduced ability and slower rate of decline was observed for all tests. Our results indicate that the poly-T variant has the ability to interact with transcription machinery and differentially modulate reporter gene expression and influence vocabulary ability and decline with age.

Citing Articles

Alzheimer's disease cortical morphological phenotypes are associated with TOMM40'523-APOE haplotypes.

Honea R, Hunt S, Lepping R, Vidoni E, Morris J, Watts A Neurobiol Aging. 2023; 132:131-144.

PMID: 37804609 PMC: 10763175. DOI: 10.1016/j.neurobiolaging.2023.09.001.


TOMM40 '523 Genotype Distinguishes Patterns of Cognitive Improvement for Executive Function in APOEɛ3 Homozygotes.

Watts A, Haneline S, Welsh-Bohmer K, Wu J, Alexander R, Swerdlow R J Alzheimers Dis. 2023; 95(4):1697-1707.

PMID: 37718796 PMC: 10578241. DOI: 10.3233/JAD-230066.


The APOE-TOMM40 Humanized Mouse Model: Characterization of Age, Sex, and PolyT Variant Effects on Gene Expression.

Gottschalk W, Mahon S, Hodgson D, Barrera J, Hill D, Wei A J Alzheimers Dis. 2023; 94(4):1563-1576.

PMID: 37458041 PMC: 10733864. DOI: 10.3233/JAD-230451.


The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer's Disease.

Chhimpa N, Singh N, Puri N, Kayath H J Alzheimers Dis. 2023; 94(s1):S453-S472.

PMID: 37393492 PMC: 10473122. DOI: 10.3233/JAD-220514.


An increase in mitochondrial TOM activates apoptosis to drive retinal neurodegeneration.

Periasamy A, Mitchell N, Zaytseva O, Chahal A, Zhao J, Colman P Sci Rep. 2022; 12(1):21634.

PMID: 36517509 PMC: 9750964. DOI: 10.1038/s41598-022-23280-z.